Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - compresse - methylprednisolonum 4 mg, lactosum monohydricum 80 mg, maydis per amylum, zucchero 1,5 mg, calcio stearas, pro compresso. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - compresse - methylprednisolonum 100 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, methylcellulosum, magnesii stearas, e 132, pro compresso corresp., natrium 2-3 mg. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - compresse - methylprednisolonum 16 mg, lactosum monohydricum 159 mg, maydis per amylum, paraffinum liquido, biomassa 2,8 mg, calcio stearas, pro compresso. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - compresse - methylprednisolonum 32 mg, lactosum monohydricum 318 mg, maydis per amylum, paraffinum liquido, zucchero 5.6 mg, calcio stearas, pro compresso. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - pulver und lösungsmittel zur herstellung einer injektions-/infusionslösung - praeparatio cryodesiccata: methylprednisolonum 500 mg ut methylprednisoloni natrii succinas, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii hydroxidum q.s. ad ph pro vitro corresp. natrium 58.3 mg. solvens: alcohol benzylicus 70.2 mg, aqua ad iniectabile ad solutionem pro 7.8 ml. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - pulver und lösungsmittel zur herstellung einer injektions-/infusionslösung - praeparatio cryodesiccata: methylprednisolonum 1 g ut methylprednisoloni natrii succinas, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii hydroxidum q.s. ad ph pro vitro corresp. natrium 116.8 mg. solvens: alcohol benzylicus 140.4 mg, aqua ad iniectabile ad solutionem pro 15.6 ml. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - pulver und lösungsmittel zur herstellung einer injektions-/infusionslösung - praeparatio cryodesiccata: methylprednisolonum 40 mg ut methylprednisoloni natrii succinas, saccharum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii hydroxidum, pro vitro corresp. natrium 8.8 mg. solvens: aqua ad iniectabile. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - pulver und lösungsmittel zur herstellung einer injektions-/infusionslösung - praeparatio cryodesiccata: methylprednisolonum 125 mg ut methylprednisoloni natrii succinas, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii hydroxidum, pro vitro corresp. natrium 14.6 mg. solvens: aqua ad iniectabile. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - methylprednisolonum - pulver und lösungsmittel zur herstellung einer injektions-/infusionslösung - praeparatio cryodesiccata: methylprednisolonum 250 mg ut methylprednisoloni natrii succinas, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii hydroxidum, pro vitro corresp. natrium 29.2 mg. solvens: aqua ad iniectabile. - glucocorticoidi-therapie - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - prednisolonum - compresse - prednisolonum 5 mg, isomaltum 93 mg, amylum pregelificatum, carboxymethylamylum natricum corresp. natrium 0.3 mg, magnesii stearas pro compresso. - glukokortikosteroid-therapie - synthetika